Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy

Publisher： Karger

E-ISSN： 1423-0232|81|1|1-10

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.1, 2011-12, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 31, Iss. 10, 2008-09 ,pp. : 550-555

Karger

Access to resources Recommend Favorite

Hepatocellular Carcinoma 2009 and Beyond: from the Surveillance to Molecular Targeted Therapy

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

Management of Hepatocellular Carcinoma: From Prevention to Molecular Targeted Therapy

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 2008 Okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 439-452

John Wiley & Sons Inc

Access to resources Recommend Favorite